share_log

Maxim Group Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $4

Maxim Group Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $4

美心集團以買入評級啟動藍水疫苗覆蓋,宣布目標價格為 4 美元
Benzinga Real-time News ·  2022/12/08 08:42

Maxim Group analyst Jason McCarthy initiates coverage on Blue Water Vaccines (NASDAQ:BWV) with a Buy rating and announces Price Target of $4.

Maxim Group分析師Jason McCarthy以買入評級啟動藍水疫苗(納斯達克:BWV)的報道,並宣佈目標價為4美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論